论文--现代中医学填补动脉瘤药物治疗空白.docVIP

现代中医学填补动脉瘤药物治疗空白 Modern Chinese medicine to fill the gaps in the treatment of aneurysms 内容摘要： 动脉瘤属于由遗传缺陷、感染、代谢障碍、循环障碍、外伤等因素，主要是由营养代谢障碍导致循环系统动脉血管形态损伤，导致人体循环系统功能障碍和血管组织结构与形态损伤，发生在颅内、外周或腹主动脉各段膨隆突起或血管壁组织分层的一类致死率高达95%的一类危重病症。世界医学体系只能等到动脉瘤突发，动脉壁突然大幅度膨胀或破裂急救时被检出进行外科干预来延缓患者1—3年生存期。医学界至今还没有动脉瘤的内科治疗技术和药物。 传统中医学里是找不到与动脉瘤相对应的疾病，只有笼统的“癥瘕、积聚、痞块”等针对人体病理性组织结构异常的辨证模式，不适用于动脉瘤病因辨证而难以准确指导动脉瘤的处方用药。笔者根据代谢障碍、循环器官损害、动脉膨出扩张乃至破裂的病理特征，研究出本病在传统中医临床诊断当中的特殊辩证规律，确立了本病以“湿、痰、气滞、血瘀为疾病演变进展规律的辨证模式，拟定出以“利湿排酯、清障逐瘀、行气减压、补气运血、再生修复”为治疗原则指导临床用药。 实施临床紧急治疗时要把握以下两个要点： 1.及时有效调控血压和腹腔压力，配备合理临床监护和适应性体位，严防瘤体破裂出血，避免意外发生。 2.通过实施中药进行活血、祛风、解痉、降压的有效治疗，切实保护受害器官，缓解痛苦程度。 根据动脉瘤患者的相应病理阶段的不同特点确立与之相适应的4项基本治疗法则： 1“行气化水、活血祛瘀、导滞减压”是急救期的治疗宗旨 2“除湿降脂清理障碍，修复血液循环”是治疗的基本措施 3中药治疗动脉瘤“补肝肾促修复”是维持疗效稳定的用药方针 4补肾中元气、益肝肾精血、促细胞修复贯穿治疗全过程 Content summary: Belong to the aneurysm by genetic defect, infection, metabolic disorders, circulatory disorder, trauma factors, mainly circulatory system morphology of arteries injury caused by nutritional and metabolic disorder, resulting in human circulatory system dysfunction and vascular tissue structure and morphology of injury, occurred in the intracranial, peripheral or abdominal aorta segments of bentonite long protrusions or the walls of blood vessels are hierarchically organized a mortality rate of up to 95% for a class of critical illness. The world medical system can only wait until the sudden burst of the arterial wall, the sudden expansion of the arterial wall, or rupture of the first aid to be detected when surgical intervention to delay the patient 1 - 3 years of survival. The medical profession has not yet been treated in the Department of internal medicine, the treatment technology and medicine. Traditional Chinese medicine science is to find corresponding to the aneurysm disease, only general Zhengjia, accumulation, lump in the abdomen in human pathology organization structural abnormalities of the syndrome differentiation model, does not apply to aneurysm etiology to correctly guide the aneur